Marshall Wace North America’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-632
| Closed | -$227K | – | 1382 |
|
|
2021
Q1 | $227K | Sell |
632
-14,109
| -96% | -$5.07M | ﹤0.01% | 1349 |
|
|
2020
Q4 | $7.23M | Buy |
+14,741
| New | +$7.23M | 0.03% | 452 |
|
|
2020
Q3 | – | Sell |
-3,926
| Closed | -$1.43M | – | 1198 |
|
|
2020
Q2 | $1.43M | Buy |
+3,926
| New | +$1.43M | 0.01% | 666 |
|
|
2019
Q2 | – | Sell |
-1,973
| Closed | -$1.96M | – | 1147 |
|
|
2019
Q1 | $1.96M | Buy |
+1,973
| New | +$1.96M | 0.01% | 515 |
|
|
2018
Q1 | – | Sell |
-481
| Closed | -$218K | – | 1415 |
|
|
2017
Q4 | $218K | Buy |
+481
| New | +$218K | ﹤0.01% | 1275 |
|
|
2017
Q3 | – | Sell |
-1,214
| Closed | -$425K | – | 1246 |
|
|
2017
Q2 | $425K | Buy |
+1,214
| New | +$425K | ﹤0.01% | 1115 |
|